Market Overview:
The global single-cell genome sequencing market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for single-cell genomic analysis for understanding the genetic variation and heterogeneity within cells, and for studying cancerous tumors and other diseases. In addition, technological advancements in sequencing platforms are also contributing to the growth of this market. Based on type, the global single-cell genome sequencing market is segmented into NGS, PCR, qPCR, microarray, and MDA. The NGS segment is expected to account for the largest share of this market in 2018 owing to its high accuracy and throughput. Based on application, this market is segmented into CTCs (circulating tumor cells), differentiation/ reprogramming , genomic variation , subpopulation characterization , and others . The CTCs application segment is expected to account for the largest share of this market in 2018 owing its ability detect cancerous cells present in blood samples .
Product Definition:
Single-cell genome sequencing is the process of decoding the genetic information within a single cell. This technology can be used to study the genetic makeup of individual cells and track their development over time. Single-cell genome sequencing can also be used to detect mutations in cancer cells and other rare cells.
NGS:
The Next-Generation Sequencing (NGS) is a high-throughput technique used to sequence the genome of single cells. It offers several advantages over conventional sequencing methods, such as whole-genome amplification and PCR. The major advantage of NGS is that it allows analysis of a large number of genes at once, which makes it possible to study biological processes at the molecular level.
PCR:
Polymerase Chain Reaction (PCR) is a technique used to amplify the DNA sequence of a particular region of interest from an unknown DNA sequence. The technology has been applied successfully in various genomic studies such as genotyping, genetic fingerprints identification, and species identification. PCR is also used for detecting and quantifying specific gene or biomarker expression levels in clinical diagnostic settings.
Application Insights:
The others application segment includes research applications and clinical applications. The clinical application segment dominated the overall market in terms of revenue in 2017, owing to the rising prevalence of cancer and other genetic diseases. According to data published by WHO, it has been estimated that approximately 24 million people died from cancer worldwide in 2016. A significant increase in the incidence of these diseases coupled with limited treatment options is expected to contribute towards high demand for single-cell genome sequencing during the forecast period.
Clinical diagnostics accounted for a substantial share within this segment due to an increasing number of initiatives undertaken by governments and non-government organizations (NGOs) aimed at improving access to diagnostic services across developing countries such as India, China, Brazil etcetera.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a substantial number of players, availability of advanced technologies and high investment in R&D. Moreover, increasing prevalence of cancer is one major factor responsible for North America’s dominance. According to the American Cancer Society, Inc., 1 out of 4 people will be diagnosed with cancer during their lifetime as reported by CDC in 2016; hence it is highly prevalent across this region and drives demand for CAGS services.
Asia Pacific region is expected to grow at a lucrative rate over the forecast period owing to rising disposable income coupled with growing health awareness among population groups especially geriatric ones which are more prone towards various chronic diseases including cancers that require genomic analysis for proper diagnosis and treatment planning.
Growth Factors:
- Increasing demand for personalized medicines
- Rising prevalence of cancer and other diseases
- Technological advancements in single-cell sequencing platforms and bioinformatics tools
- Growing investments in life sciences research by public and private organizations
- Proliferation of genomics data sharing initiatives
Scope Of The Report
Report Attributes
Report Details
Report Title
Single-Cell Genome Sequencing Market Research Report
By Type
NGS, PCR, qPCR, Microarray, MDA
By Application
CTCs, Differentiation/ reprogramming, Genomic variation, Subpopulation characterization, Others
By Companies
Bio-Rad Laboratories, 10x Genomics, Novogene, Fluidigm, BGI, Illumina, Inc., Oxford Nanopore Technologies, Pacific Biosciences, Thermo Fisher Scientific, Inc., QIAGEN, F Hoffmann-La Roche Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
170
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Single-Cell Genome Sequencing Market Report Segments:
The global Single-Cell Genome Sequencing market is segmented on the basis of:
Types
NGS, PCR, qPCR, Microarray, MDA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
CTCs, Differentiation/ reprogramming, Genomic variation, Subpopulation characterization, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad Laboratories
- 10x Genomics
- Novogene
- Fluidigm
- BGI
- Illumina, Inc.
- Oxford Nanopore Technologies
- Pacific Biosciences
- Thermo Fisher Scientific, Inc.
- QIAGEN
- F Hoffmann-La Roche Ltd.
Highlights of The Single-Cell Genome Sequencing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- NGS
- PCR
- qPCR
- Microarray
- MDA
- By Application:
- CTCs
- Differentiation/ reprogramming
- Genomic variation
- Subpopulation characterization
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Single-Cell Genome Sequencing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Single-cell genome sequencing is a technique that uses DNA sequencing to determine the complete genetic sequence of a single cell. This information can be used to study the biology and behavior of individual cells, as well as identify potential disease markers.
Some of the major companies in the single-cell genome sequencing market are Bio-Rad Laboratories, 10x Genomics, Novogene, Fluidigm, BGI, Illumina, Inc., Oxford Nanopore Technologies, Pacific Biosciences, Thermo Fisher Scientific, Inc., QIAGEN, F Hoffmann-La Roche Ltd..
The single-cell genome sequencing market is expected to grow at a compound annual growth rate of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Single-Cell Genome Sequencing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Single-Cell Genome Sequencing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Single-Cell Genome Sequencing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Single-Cell Genome Sequencing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Single-Cell Genome Sequencing Market Size & Forecast, 2018-2028
4.5.1 Single-Cell Genome Sequencing Market Size and Y-o-Y Growth
4.5.2 Single-Cell Genome Sequencing Market Absolute $ Opportunity
Chapter 5 Global Single-Cell Genome Sequencing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Single-Cell Genome Sequencing Market Size Forecast by Type
5.2.1 NGS
5.2.2 PCR
5.2.3 qPCR
5.2.4 Microarray
5.2.5 MDA
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Single-Cell Genome Sequencing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Single-Cell Genome Sequencing Market Size Forecast by Applications
6.2.1 CTCs
6.2.2 Differentiation/ reprogramming
6.2.3 Genomic variation
6.2.4 Subpopulation characterization
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Single-Cell Genome Sequencing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Single-Cell Genome Sequencing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Single-Cell Genome Sequencing Analysis and Forecast
9.1 Introduction
9.2 North America Single-Cell Genome Sequencing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Single-Cell Genome Sequencing Market Size Forecast by Type
9.6.1 NGS
9.6.2 PCR
9.6.3 qPCR
9.6.4 Microarray
9.6.5 MDA
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Single-Cell Genome Sequencing Market Size Forecast by Applications
9.10.1 CTCs
9.10.2 Differentiation/ reprogramming
9.10.3 Genomic variation
9.10.4 Subpopulation characterization
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Single-Cell Genome Sequencing Analysis and Forecast
10.1 Introduction
10.2 Europe Single-Cell Genome Sequencing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Single-Cell Genome Sequencing Market Size Forecast by Type
10.6.1 NGS
10.6.2 PCR
10.6.3 qPCR
10.6.4 Microarray
10.6.5 MDA
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Single-Cell Genome Sequencing Market Size Forecast by Applications
10.10.1 CTCs
10.10.2 Differentiation/ reprogramming
10.10.3 Genomic variation
10.10.4 Subpopulation characterization
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Single-Cell Genome Sequencing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Single-Cell Genome Sequencing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Single-Cell Genome Sequencing Market Size Forecast by Type
11.6.1 NGS
11.6.2 PCR
11.6.3 qPCR
11.6.4 Microarray
11.6.5 MDA
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Single-Cell Genome Sequencing Market Size Forecast by Applications
11.10.1 CTCs
11.10.2 Differentiation/ reprogramming
11.10.3 Genomic variation
11.10.4 Subpopulation characterization
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Single-Cell Genome Sequencing Analysis and Forecast
12.1 Introduction
12.2 Latin America Single-Cell Genome Sequencing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Single-Cell Genome Sequencing Market Size Forecast by Type
12.6.1 NGS
12.6.2 PCR
12.6.3 qPCR
12.6.4 Microarray
12.6.5 MDA
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Single-Cell Genome Sequencing Market Size Forecast by Applications
12.10.1 CTCs
12.10.2 Differentiation/ reprogramming
12.10.3 Genomic variation
12.10.4 Subpopulation characterization
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Single-Cell Genome Sequencing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Single-Cell Genome Sequencing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Single-Cell Genome Sequencing Market Size Forecast by Type
13.6.1 NGS
13.6.2 PCR
13.6.3 qPCR
13.6.4 Microarray
13.6.5 MDA
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Single-Cell Genome Sequencing Market Size Forecast by Applications
13.10.1 CTCs
13.10.2 Differentiation/ reprogramming
13.10.3 Genomic variation
13.10.4 Subpopulation characterization
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Single-Cell Genome Sequencing Market: Competitive Dashboard
14.2 Global Single-Cell Genome Sequencing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad Laboratories
14.3.2 10x Genomics
14.3.3 Novogene
14.3.4 Fluidigm
14.3.5 BGI
14.3.6 Illumina, Inc.
14.3.7 Oxford Nanopore Technologies
14.3.8 Pacific Biosciences
14.3.9 Thermo Fisher Scientific, Inc.
14.3.10 QIAGEN
14.3.11 F Hoffmann-La Roche Ltd.
